Core Viewpoint - Inspire Medical Systems (INSP) has shown a 6.1% gain over the past four weeks, with a mean price target of 187.01 [1] Price Target Analysis - The average of 15 short-term price targets ranges from a low of 270, with a standard deviation of $26.31, suggesting variability in analyst estimates [2] - The lowest estimate indicates a 1.6% increase, while the highest suggests a 44.4% upside, highlighting the range of analyst opinions [2] Analyst Consensus and Earnings Estimates - Analysts have shown a strong agreement in revising earnings estimates higher, which is a positive indicator for potential stock upside [4][9] - The Zacks Consensus Estimate for the current year has increased by 6.3% over the past month, with six estimates going higher and two lower [10] Zacks Rank and Investment Potential - INSP holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [11] - This rank, along with a strong externally-audited track record, suggests a solid potential upside for the stock in the near term [11] Caution on Price Targets - While price targets can provide insights, they should be approached with skepticism as they may not reliably indicate actual stock price movements [5][8]
How Much Upside is Left in Inspire (INSP)? Wall Street Analysts Think 25.88%